UnknownNot Applicable

The Impact of Provider Demographics on Patients' Continuity of Care

United States415 participantsStarted 2020-08-12

Plain-language summary

The race concordance of providers to their patients impacts a patient's investment and agency in the patient-provider relationship. The mistrust of medicine within the African American population remains and patients feel unengaged in their care. Race concordant provider-patient rela-tionships would improve the equity of patient care in our clinic.

Who can participate

Age range

18 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria * Female Patient seeing OB/GYN resident at FMC * 18 years or older * \<36 weeks pregnant or GYN patient * If GYN patient, must have problem requiring follow-up within 6 months * Have not previously completed the survey Exclusion criteria * Less than 18 years of age * High risk clinic patients (Tuesday afternoons) * Patients without a follow-up less than 6 months as scheduled at check out

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Patient's rate of follow-up

Timeframe: 6 months

Trial details

NCT IDNCT04315402

SponsorTriHealth Inc.

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-03

Contact for this trial

Ganga Devaiah, MS

513-862-2341 ganga_devaiah@trihealth.com

View on ClinicalTrials.gov More Race Concordant Patient-provider Relationship trials